Ambroxol lozenge

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyPharyngitis

Phase 1

Investigation of the Metabolism and Pharmacokinetics of Ambroxol in Healthy Male Volunteers

CompletedNCT02194257

Boehringer IngelheimHealthy

Start: 2008-10-31Updated: 2014-07-18

Phase 3

Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis

CompletedNCT00144274

Boehringer IngelheimPharyngitis

Start: 2005-04-30End: 2005-11-30Target: 220Updated: 2013-10-29